Recommended

Molecular Characterization And Resistance Of H....

P Falciparum Allele Frequencies In A Holoendemi...

Azithromycin Treatment Of Drug Induced Gingival...

Characterization Of Cephalosporinases Produced ...

Prescribing Antibiotics For Pediatric Dental Pa...

0 votes
Global Financing And Long-term Technical Assistance For Multidrug-resistant Tuberculosis: Scaling Up Access To Treatment
Author: Thomas J. Hwang, Salmaan Keshavjee
Publisher: Derivative Works
6 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
ISBN/ISSN: 1549-1676
DOI: 10.1371/1001738
Follow this publisher

Share this publication:

Description:

Multidrug-resistant tuberculosis (MDRTB), strains of Mycobacterium tuberculosis resistant to the first-line antituberculosis drugs rifampicin and isoniazid, is a global public health concern and remains a leading cause of mortality and morbidity in low- and middle-income countries [1]. In response, World Health Organization (WHO) member states have called for action to ‘‘achieve universal access to diagnosis and treatment of multidrugresistant and extensively drug-resistant tuberculosis’’ [2]. However, the drive to eradicate MDR-TB using current strategies remains an uphill battle [3,4]. Extensively drug-resistant tuberculosis (XDRTB), a form of MDR-TB with additional resistance to the backbone of the secondline antituberculosis regimen—fluoroquinolones and injectable agents—has been officially reported in 92 countries.

About the publisher:

We are a publishing house devoted to reuse CC-BY licensed published materials.

 

Using CC-BY licenses:

YOU ARE FREE TO:

  • Adapt — remix, transform, and build upon the material
  • for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

UNDER THE FOLLOWING TERMS:

  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others
    from doing anything the license permits.

NOTICES:

  • You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
  • No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Select a payment method